BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24523453)

  • 1. Does valganciclovir have a role in glioblastoma therapy?
    Cobbs CS
    Neuro Oncol; 2014 Mar; 16(3):330-1. PubMed ID: 24523453
    [No Abstract]   [Full Text] [Related]  

  • 2. CMV infection and glioma, a highly controversial concept struggling in the clinical arena.
    Wick W; Platten M
    Neuro Oncol; 2014 Mar; 16(3):332-3. PubMed ID: 24523454
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversies in neuro-oncology: does valganciclovir have a role in the treatment of high-grade gliomas?
    Wen PY
    Neuro Oncol; 2014 Mar; 16(3):329. PubMed ID: 24523452
    [No Abstract]   [Full Text] [Related]  

  • 4. The legend of cytomegalovirus and glioblastoma lives on.
    Weller M; Soffietti R; Brada M
    Neuro Oncol; 2014 Jan; 16(1):166. PubMed ID: 24311642
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenging cytomegalovirus data in glioblastoma.
    Wick W; Wick A; Platten M
    Neuro Oncol; 2014 Jan; 16(1):165. PubMed ID: 24353326
    [No Abstract]   [Full Text] [Related]  

  • 6. [Questionable effect of antiviral therapy in malignant brain tumors].
    Kinhult S; Werlenius K; Hallbeck AL; Nyström PW; Männikkö V; Johansson M
    Lakartidningen; 2014 Apr 29-May 13; 111(18-19):809. PubMed ID: 24855749
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inconclusive data].
    Kinhult S; Werlenius K; Hallbeck AL; Nyström PW; Männikkö V; Johansson M
    Lakartidningen; 2014 Jul 2-15; 111(27-28):1192. PubMed ID: 25162111
    [No Abstract]   [Full Text] [Related]  

  • 8. VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma.
    Ottenhausen M; Bodhinayake I; Schaefer PM; Boockvar JA
    Neurosurgery; 2014 Apr; 74(4):N17-8. PubMed ID: 24642991
    [No Abstract]   [Full Text] [Related]  

  • 9. VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma.
    Ottenhausen M; Bodhinayake I; Schaefer PM; Boockvar JA
    Neurosurgery; 2014 Feb; 74(2):N23-4. PubMed ID: 24435151
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain cancer. A viral link to glioblastoma?
    Miller G
    Science; 2009 Jan; 323(5910):30-1. PubMed ID: 19119195
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.
    Stragliotto G; Rahbar A; Solberg NW; Lilja A; Taher C; Orrego A; Bjurman B; Tammik C; Skarman P; Peredo I; Söderberg-Nauclér C
    Int J Cancer; 2013 Sep; 133(5):1204-13. PubMed ID: 23404447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in patients with glioblastoma receiving valganciclovir.
    Söderberg-Nauclér C; Rahbar A; Stragliotto G
    N Engl J Med; 2013 Sep; 369(10):985-6. PubMed ID: 24004141
    [No Abstract]   [Full Text] [Related]  

  • 13. Immortal time bias in retrospective analysis: is there a survival benefit in patients with glioblastoma who received prolonged treatment of adjuvant valganciclovir?
    Liu CJ; Hu YW
    Int J Cancer; 2014 Jul; 135(1):250-1. PubMed ID: 24338590
    [No Abstract]   [Full Text] [Related]  

  • 14. [Valganciclovir maintenance therapy in AIDS: treatment failure due to the development of cytomegalovirus resistance to ganciclovir].
    Couzigou C; Mazeron MC; Escaut L; Merad M; Vittecoq D
    Med Mal Infect; 2005 Feb; 35(2):98-100. PubMed ID: 15780901
    [No Abstract]   [Full Text] [Related]  

  • 15. Valganciclovir versus IV ganciclovir for therapy of cytomegalovirus viremia: has victory been achieved?
    Avery RK
    Am J Transplant; 2007 Sep; 7(9):2062-3. PubMed ID: 17697259
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.
    Solomon IH; Ramkissoon SH; Milner DA; Folkerth RD
    J Neuropathol Exp Neurol; 2014 Nov; 73(11):994-8. PubMed ID: 25289896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.
    Söderberg-Naucler C; Peredo I; Rahbar A; Hansson F; Nordlund A; Stragliotto G
    Int J Cancer; 2014 Jul; 135(1):248-9. PubMed ID: 24338548
    [No Abstract]   [Full Text] [Related]  

  • 18. Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study.
    Peredo I; Helldén A; Wolmer-Solberg N; Pohanka A; Stragliotto G; Rahbar A; Ståhle L; Bellander BM; Söderberg-Nauclér C
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26670887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valganciclovir in patients with glioblastoma.
    Hellstrand K; Martner A; Bergström T
    N Engl J Med; 2013 Nov; 369(21):2066. PubMed ID: 24256397
    [No Abstract]   [Full Text] [Related]  

  • 20. Valganciclovir in patients with glioblastoma.
    Söderberg-Nauclér C; Peredo I; Stragliotto G
    N Engl J Med; 2013 Nov; 369(21):2066-7. PubMed ID: 24256396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.